As of 4:00pm ET
| +0.10 / +1.83%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 14.00 and a low estimate of 11.00. The median estimate represents a +115.83% increase from the last price of 5.56.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.